Medicare Drug Price Bill Returning to Senate on Democrats’ Watch

Jan. 13, 2021, 8:42 PM

The Senate debate over prescription drug pricing will pick up where it left off last year as the chamber undergoes a change in control, a key Democrat said.

Ron Wyden (D-Ore.), in line to lead the Senate Finance Committee in this Congress, said he plans to build off a package of drug pricing measures he and the outgoing chairman, Charles Grassley (R-Iowa), created. That package would cap drug costs for Medicare beneficiaries and force drug manufacturers to provide Medicare inflation rebates, paying back the government for price increases.

“We’ve got to take bold action on prescription drug prices,” he told...

To read the full article log in. To learn more about a subscription click here.